UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

Pharmacovigilance Regulatory Actions by National Pharmacovigilance Centres in Fourteen Middle Eastern Countries Following COVID-19 Pandemic

Drug safety, 2022-10, Vol.45 (10), p.1175-1176

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and Effectiveness Monitoring of Remdesivir as Covid-19 Medicines through Post- Authorization Safety Studies in Indonesia

Drug safety, 2023-11, Vol.46 (11), p.1184-1184

2023

Link zum Volltext

Verfügbarkeit prüfen

Reports on long-lasting reactions following Covid-19 vaccinations in Switzerland

Drug safety, 2023-11, Vol.46 (11), p.1217-1218

2023

Link zum Volltext

Verfügbarkeit prüfen

Thyroid Status, Timing of Vaccine and Sex as Determinants of Persistent Health Issues After COVID-19 Vaccines

Drug safety, 2023-11, Vol.46 (11), p.1180-1181

2023

Link zum Volltext

Verfügbarkeit prüfen

Role of Background Incidence in Signal Detection; Observed/ Expected Analysis of Classical Thromboembolism with COVID 19 Vaccines in The Netherlands

Drug safety, 2022-10, Vol.45 (10), p.1308-1309

2022

Link zum Volltext

Verfügbarkeit prüfen

Factors Influencing Patient Reporting of Adverse Reactions to Covid-19 Vaccines

Drug safety, 2022-10, Vol.45 (10), p.1178-1178

2022

Link zum Volltext

Verfügbarkeit prüfen

Covid-19 Vaccines: Is the Seriousness Criterion "Medically Important" Applied Correctly in Reports and Are There Differences between HCPs and Non-HCPs?

Drug safety, 2022-10, Vol.45 (10), p.1186-1187

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of the Inclusion of Covid-19 Vaccines in the National Pharmacovigilance Database on the Measurement of Disproportionality

Drug safety, 2022-10, Vol.45 (10), p.1182-1183

2022

Link zum Volltext

Verfügbarkeit prüfen

Fixed Drug Eruption after ChAdOx1 nCoV-19 Vaccine

Drug safety, 2022-10, Vol.45 (10), p.1197-1197

2022

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous Reports of Delayed Urticaria Following Booster Vaccination with Spikevax® in Switzerland

Drug safety, 2022-10, Vol.45 (10), p.1233-1233

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacovigilance Among Patients from the Perspective of Pharmacists: A Survey Study in Morocco

Drug safety, 2022-10, Vol.45 (10), p.1211-1211

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral Presentation: A Revised Time-to-Onset Signal Detection Algorithm in the Context of Mass Vaccination

Drug safety, 2022-10, Vol.45 (10), p.1122-1122

Holle, L V

2022

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 Vaccination Errors During Tunisian Vaccination Campaign Collected from March 13, 2021 to September 29, 2021

Drug safety, 2022-10, Vol.45 (10), p.1144-1144

2022

Link zum Volltext

Verfügbarkeit prüfen

The Impact of the COVID-19 Pandemic on Spontaneous Reporting of Adverse Drug Reactions in the Central Region of Portugal

Drug safety, 2022-10, Vol.45 (10), p.1198-1198

2022

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Mobile Apps for Spontaneous Reporting: Experience from COVID-19 Vaccines Safety Surveillance

Drug safety, 2022-10, Vol.45 (10), p.1229-1229

2022

Link zum Volltext

Verfügbarkeit prüfen

Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands"/Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands"

Drug safety, 2022-08, Vol.45 (8), p.923-926

2022

Link zum Volltext

Verfügbarkeit prüfen

Leveraging on Community Health Volunteers to Educate the Public on Adverse Events Following Immunization and Dispel Myths and Misconceptions

Drug safety, 2021-12, Vol.44 (12), p.1448-1448

2021

Link zum Volltext

Verfügbarkeit prüfen

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

Drug safety, 2020-07, Vol.43 (7), p.615-617

2020

Link zum Volltext

Verfügbarkeit prüfen

Guillan-Barre´ Syndrome Following COVID-19 Vaccines: Analysis of the Vaccine Adverse Event Reporting System (VAERS) Database

Drug safety, 2022-10, Vol.45 (10), p.1208-1209

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the Quality of MedDRA Coding in a Sample of COVID-19 Vaccine Medication Error Data

Drug safety, 2022-10, Vol.45 (10), p.1139-1140

2022

Link zum Volltext

Verfügbarkeit prüfen

How Covid-19 Pandemic Affected the National Pharmacovigilance System in the Czech Republic

Drug safety, 2022-10, Vol.45 (10), p.1185-1185

2022

Link zum Volltext

Verfügbarkeit prüfen

Active Monitoring of Adverse Events in a Closed Population: Contributions from Colombia to COVID-19 Vaccines Safety

Drug safety, 2022-10, Vol.45 (10), p.1180-1181

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacovigilance Before and After COVID-19 Pandemic: A 3- Years Analysis of Adverse Drug Reactions Reporting at the University Hospital of Catania

Drug safety, 2022-10, Vol.45 (10), p.1213-1213

2022

Link zum Volltext

Verfügbarkeit prüfen

Acute Angle Closure Glaucoma Following COVID-19 Vaccination

Drug safety, 2022-10, Vol.45 (10), p.1198-1199

2022

Link zum Volltext

Verfügbarkeit prüfen

How a Community Approach Can Drive Pharmacovigilance Activities in Low-Resource Settings during a Public Health Emergency: Lessons from COVID-19

Drug safety, 2022-10, Vol.45 (10), p.1191-1191

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 190

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR All Journals

ThemaSars-Cov-2

KollektionSpringer Nature - Complete Springer Journals

Zeitschrift / SerieDrug Safety

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(190)

Publikationsform

Artikel
(190)

Sprache

Englisch
(190)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Coronaviruses
(190)
Vaccines
(142)
Covid-19 Vaccines
(139)
Pharmacovigilance
(108)
Immunization
(106)
Covid-19
(96)
Vaccination
(85)
Safety
(75)
Pandemics
(67)
Patients
(63)
Pharmacology
(60)
Medicine
(55)
Adverse Events
(54)
Viral Diseases
(52)
Severe Acute Respiratory Syndrome Coronavirus 2
(51)
Drug Safety And Pharmacovigilance
(47)
Life Sciences & Biomedicine
(47)
Medicine & Public Health
(47)
Pharmacology & Pharmacy
(47)
Pharmacology/toxicology
(47)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacovigilance Regulatory Actions by National Pharmacovigilance Centres in Fourteen Middle Eastern Countries Following COVID-19 Pandemic

Safety and Effectiveness Monitoring of Remdesivir as Covid-19 Medicines through Post- Authorization Safety Studies in Indonesia

Reports on long-lasting reactions following Covid-19 vaccinations in Switzerland

Thyroid Status, Timing of Vaccine and Sex as Determinants of Persistent Health Issues After COVID-19 Vaccines

Role of Background Incidence in Signal Detection; Observed/ Expected Analysis of Classical Thromboembolism with COVID 19 Vaccines in The Netherlands

Factors Influencing Patient Reporting of Adverse Reactions to Covid-19 Vaccines

Covid-19 Vaccines: Is the Seriousness Criterion "Medically Important" Applied Correctly in Reports and Are There Differences between HCPs and Non-HCPs?

Impact of the Inclusion of Covid-19 Vaccines in the National Pharmacovigilance Database on the Measurement of Disproportionality

Fixed Drug Eruption after ChAdOx1 nCoV-19 Vaccine

Spontaneous Reports of Delayed Urticaria Following Booster Vaccination with Spikevax® in Switzerland

Pharmacovigilance Among Patients from the Perspective of Pharmacists: A Survey Study in Morocco

Oral Presentation: A Revised Time-to-Onset Signal Detection Algorithm in the Context of Mass Vaccination

COVID-19 Vaccination Errors During Tunisian Vaccination Campaign Collected from March 13, 2021 to September 29, 2021

The Impact of the COVID-19 Pandemic on Spontaneous Reporting of Adverse Drug Reactions in the Central Region of Portugal

The Impact of Mobile Apps for Spontaneous Reporting: Experience from COVID-19 Vaccines Safety Surveillance

Leveraging on Community Health Volunteers to Educate the Public on Adverse Events Following Immunization and Dispel Myths and Misconceptions

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

Guillan-Barre´ Syndrome Following COVID-19 Vaccines: Analysis of the Vaccine Adverse Event Reporting System (VAERS) Database

Assessment of the Quality of MedDRA Coding in a Sample of COVID-19 Vaccine Medication Error Data

How Covid-19 Pandemic Affected the National Pharmacovigilance System in the Czech Republic

Active Monitoring of Adverse Events in a Closed Population: Contributions from Colombia to COVID-19 Vaccines Safety

Pharmacovigilance Before and After COVID-19 Pandemic: A 3- Years Analysis of Adverse Drug Reactions Reporting at the University Hospital of Catania

Acute Angle Closure Glaucoma Following COVID-19 Vaccination

How a Community Approach Can Drive Pharmacovigilance Activities in Low-Resource Settings during a Public Health Emergency: Lessons from COVID-19

Aktive Filter

Suchergebnisse filtern